WallStreetZenWallStreetZen

NASDAQ: DRIO
Dariohealth Corp Stock

$1.43+0.08 (+5.93%)
Updated Jul 12, 2024
DRIO Price
$1.43
Fair Value Price
N/A
Market Cap
$42.79M
52 Week Low
$0.68
52 Week High
$4.26
P/E
-0.85x
P/B
0.55x
P/S
2.77x
PEG
N/A
Dividend Yield
N/A
Revenue
$19.04M
Earnings
-$53.78M
Gross Margin
27.6%
Operating Margin
-292.52%
Profit Margin
-314.5%
Debt to Equity
0.76
Operating Cash Flow
-$39M
Beta
1.16
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

DRIO Overview

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DRIO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

DRIO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DRIO is good value based on its book value relative to its share price (0.55x), compared to the US Diagnostics & Research industry average (4.12x)
P/B vs Industry Valuation
DRIO is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more DRIO due diligence checks available for Premium users.

Be the first to know about important DRIO news, forecast changes, insider trades & much more!

DRIO News

Valuation

DRIO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.85x
Industry
38.21x
Market
32.2x

DRIO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.55x
Industry
4.12x
DRIO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

DRIO's financial health

Profit margin

Revenue
$5.8M
Net Income
-$7.2M
Profit Margin
-159.9%
DRIO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
DRIO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$137.0M
Liabilities
$58.9M
Debt to equity
0.76
DRIO's short-term assets ($52.51M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DRIO's short-term assets ($52.51M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DRIO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DRIO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$13.1M
Investing
-$8.9M
Financing
$20.2M
DRIO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

DRIO vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
DRIO$42.79M+5.93%-0.85x0.55x
OCX$44.50M+5.71%-0.66x3.84x
TTOO$48.27M+10.46%-0.48x-1.28x
XGN$33.53M-0.26%-1.77x1.68x
VNRX$54.58M+2.17%-1.43x-3.50x

Dariohealth Stock FAQ

What is Dariohealth's quote symbol?

(NASDAQ: DRIO) Dariohealth trades on the NASDAQ under the ticker symbol DRIO. Dariohealth stock quotes can also be displayed as NASDAQ: DRIO.

If you're new to stock investing, here's how to buy Dariohealth stock.

What is the 52 week high and low for Dariohealth (NASDAQ: DRIO)?

(NASDAQ: DRIO) Dariohealth's 52-week high was $4.26, and its 52-week low was $0.68. It is currently -66.43% from its 52-week high and 110.29% from its 52-week low.

How much is Dariohealth stock worth today?

(NASDAQ: DRIO) Dariohealth currently has 29,923,250 outstanding shares. With Dariohealth stock trading at $1.43 per share, the total value of Dariohealth stock (market capitalization) is $42.79M.

Dariohealth stock was originally listed at a price of $4,482.00 in Apr 9, 2013. If you had invested in Dariohealth stock at $4,482.00, your return over the last 11 years would have been -99.97%, for an annualized return of -51.9% (not including any dividends or dividend reinvestments).

How much is Dariohealth's stock price per share?

(NASDAQ: DRIO) Dariohealth stock price per share is $1.43 today (as of Jul 12, 2024).

What is Dariohealth's Market Cap?

(NASDAQ: DRIO) Dariohealth's market cap is $42.79M, as of Jul 15, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Dariohealth's market cap is calculated by multiplying DRIO's current stock price of $1.43 by DRIO's total outstanding shares of 29,923,250.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.